This report contains market size and forecasts of Sofosbuvir/Ledipasvir Compound Drugs in global, including the following market information:
Global Sofosbuvir/Ledipasvir Compound Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sofosbuvir/Ledipasvir Compound Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Sofosbuvir/Ledipasvir Compound Drugs companies in 2021 (%)
The global Sofosbuvir/Ledipasvir Compound Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bottled Packaging Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sofosbuvir/Ledipasvir Compound Drugs include Gilead Sciences, Natco Ltd, Zydus Cadila, Hetero Drugs, Dr Reddy's Laboratories, Sun Pharmaceutical Industries, Cipla, Abbott and Biocon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sofosbuvir/Ledipasvir Compound Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sofosbuvir/Ledipasvir Compound Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sofosbuvir/Ledipasvir Compound Drugs Market Segment Percentages, by Type, 2021 (%)
Bottled Packaging
Film Coated Packaging
Global Sofosbuvir/Ledipasvir Compound Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sofosbuvir/Ledipasvir Compound Drugs Market Segment Percentages, by Application, 2021 (%)
Hepatitis C Virus (HCV) Genotype 1
Hepatitis C Virus (HCV) Genotype 3
Hepatitis C Virus (HCV) Genotype 4
Other
Global Sofosbuvir/Ledipasvir Compound Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Sofosbuvir/Ledipasvir Compound Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sofosbuvir/Ledipasvir Compound Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sofosbuvir/Ledipasvir Compound Drugs revenues share in global market, 2021 (%)
Key companies Sofosbuvir/Ledipasvir Compound Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Sofosbuvir/Ledipasvir Compound Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Natco Ltd
Zydus Cadila
Hetero Drugs
Dr Reddy's Laboratories
Sun Pharmaceutical Industries
Cipla
Abbott
Biocon
Torrent Pharmaceuticals
Lupin Ltd